coculture system using Transwell. After the coculture is done, the gene and protein expression level of PMCs in up wells are tested by RT-PCR, Immunofluorescence and Western blotting respectively. Results: The IL-10 mRNA expression level all decrease in 6e24 h while increase 24 h later, and is lower in M1 than other groups (M0, M2a, and M2c). M1 shows high expression of IL-6, IL-12, while the M2a and M2c relatively lower. The mRNA expression level of CCL17 is higher in M2a while CCL17 higher in M2c. Compared to the control group, fluorescence intensity of E-cadherin in coculture groups is decreased, and the M2c group is the most obvious with statistical difference (P < 0.05). The fluorescence intensity of a-SMA in PMCs cocultured with macrophage is higher than the control group. The gene expression of E-cadherin in PMCs is down-regulated when cocultured with M2c (P < 0.05). a-SMA expression level is up-regulated after cocultured with M2a or M2c (P < 0.05). Compared with the control group, the protein expression of E-cadherin is down-regulated and a-SMA is upregulated when cocultured with M2c. Conclusion: We successfully induce macrophage subsets (M1, M2a, M2c) differentiation using THP-1 with TPA and LPS+IFN-g, IL-4, IL-10. 2. Macrophage subtypes up-regulate a-SMA expression and down-regulate E-cadherin, promoting EMT of PMCs in some degree. And the effect of M2c is the most significant.
Objective: To investigate the role of TRPC in the process of endothelialmesenchymal transition (EMT) of human peritoneal mesothelial cells (HMrSV5) induced by high glucose.
Methods: (1) HMrSV5 cells were exposed to elevated glucose (50,75 mM) or d-mannitol (osmotic control). The expression of mRNA level of TRPC subtype (1/3/4/5/6/7) was detected by RT-PCR and immunofluorescence after culturing for different times (24 h, 48 h, 72 h). (2) Effects of 2-APB (TRPC inhibitor) on the EMT in human peritoneal mesothelial cells induced by high glucose. HMrSV5 were grouped as follow: normal group, high glucose group (HG), isotonic control group, HG+2-APB (100 mM) group, and isotonic con-trol+2-APB (100 mM) group. The expression of mRNA and protein levels of TRPC subtype (1/3/4/5/6/7), a-smooth muscle actin (a-SMA), and E-cadherin were detected by RT-PCR and immunofluorescence. Results: The expression of TRPC1/3/6 and a-SMA in high glucose (50, 75 mM) was increased, and the expression of E-cadherin was down-regulated both in a dose-dependence manner (p < 0.05). High expression of TRPC1/3/6 and a-SMA and low expression of E-cadherin could be reversed by using 2-APB (TRPC inhibitor) (p < 0.05). Conclusion: The expression of TRPC increased in human peritoneal mesothelial cells induced by high glucose. 2-APB could partly prevented EMT in human peritoneal mesothelial cells induced by high glucose. We can conclude that TRPC plays an important role in EMT process of human peritoneal mesothelial cells. Objective: To compare the different efficacies of chronic renal failure (CRF) patients between sustained low-efficiency daily dialysis (SLEDD) and intermittent haemodialysis (IHD), study the characteristics of these two kinds of dialysis patterns, in order to provide the basis for different clinical patients choosing a scientific and rational hemodialysis therapy. Methods: During the time from November 2012 to March 2015, there were 40 CRF patients who needed hemodialysis therapy from Qinghai province people's hospital gathered in this study. Recorded their personal informations, monitored their blood pressure, blood solute clearance situation and electrolyte changes before and after dialysis. Results: Two groups' post-dialysis mean blood urea nitrogen (BUN), serum creatinine (Cr), potassium (K + ), sodium (Na + ), calcium (Ca 2+ ) and phosphorus (P 3+ ), as well as their mean arterial pressure (MAP) and their mean heart rate (HR) had statistically significant differences when compared with pre-dialysis (P < 0.05). SLEDD group had a better effect than IHD group at Kt/V, potassium remove index, sodium remove index, calcium remove index and phosphorus remove index, these results were actually statistically significant (P < 0.05), blood urea nitrogen rate of decline and creatinine remove index had no significant differences (P > 0.05). The mean arterial pressure (MAP) of patients from two groups had fallen after dialysis, but SLEDD group's changing was smaller than IHD group, the difference was in fact statistically significant (P < 0.01). After dialysis, two group patients' heart rate (HR) had slowed, but SLEDD group's changing was less, the difference was really statistically significant (P < 0.05). Conclusion: Sustained low-efficiency daily dialysis (SLEDD) and intermittent haemodialysis (IHD) can effectively remove the blood small solutes of patients with chronic renal failure, effectively reduce the mean arterial pressure, and heart rate. SLEDD was more effective than IHD to lower patients' blood potassium, sodium and phosphorus, elevated their blood calcium, had higher dialysis adequacy and a more stable hemodynamics. Background: Chronic inflammation is associated with the enhancement of vascular calcification and mortality in dialysis patients. Although C-reactive protein (CRP) is commonly measured as the surrogate marker of inflammation, the impact of CRP variability upon failure of dialysis access, however, has rarely been investigated. Methods: We performed a retrospective study to evaluate the relationship of CRP variability and access failure at a medical center in southern Taiwan. The demographic and biochemical data were reviewed and collected. The access failure included the crash of arteriovenous shunt and permanent catheter. Results: A total of 318 chronic hemodialysis patients were enrolled. They were divided into three groups defined as consistently low (n Z 65), consistently high (n Z 39), and high fluctuation (n Z 214), according to CRP variability assessing at many times during 7-year dialysis period. Patients in high fluctuation group exhibited older, with higher body mass index, and greater proportion of male. Their serum albumin level and urea reduction rate were also lower. Meanwhile, significantly highest dialysis access failure rate was observed in the high fluctuation group. (consistently low: 0.10 episode/patient-year; consistently high: 0.11 episode/patient-year; high fluctuation: 0.14 episode/patient-year; p Z 0.037) Conclusion: We concluded that high prevalence of high CRP variability in chronic hemodialysis patients. Furthermore, the CRP variability was associated with dialysis access failure. This finding punctuated an important role of chronic inflammation in this common clinical condition. http://dx.doi.org/10.1016/j.hkjn.2015.09.219 of peritoneal dialysis catheter insertion were advocate complete bed rest for 1e3 days in the past years. But most patients suffered from poor dialysate drainage, drifting tube and voiding difficulty after complete bed rest. The aim of this study was to explore whether early ambulation could reduce the incidence of drift tube in peritoneal dialysis patients after peritoneal dialysis catheter insertion. Methods: We included 134 patients with end-stage renal disease (ESRD) who are undergoing peritoneal dialysis in peritoneal dialysis center of Guizhou Province. Patients were divided into 2 groups randomly. Patients with six hour ambulation after the operation of peritoneal dialysis catheter insertion were allocated to the study group, and patients who got the traditional postoperative care were assigned to the control group. No obvious difference was found between the two groups in age, gender, dialysis tube type, catheter way, and dialysis prescriptions. The incidence of drift tube in thease patiets was recorded and catheter patency rate was compared. Results: The catheter patency rate in the study group was 97.01%, and 91.04% in the control group. The incidence of drift tube was 1.49% in the study group and 5.97% in the control group. Differences between the two groups were statistically significant, P < 0.05. Conclusion: Six hour ambulation after the operation of peritoneal dialysis catheter insertion could induce the incidence of drifting tube. Objective: Chronic inflammation and malnutrition are common in dialysis patients, and negatively impact their survival prognosis. Experimental studies of omega-3 supplementation describe salutary effects on nutritional state and inflammatory markers. However, evidence from clinical trials is inconsistent. The aim of this meta-analysis was to combine evidence from randomized controlled trials (RCTs) to assess the effect of omega-3 supplementation on the change in serum C-reactive protein (CRP), interleukin (IL)-6, tumor necrosis factor (TNF)-a, and albumin. Methods: PubMed, CBM, EMBASE, CENTRAL and Cochrane renal group specialized register were searched to identify the relevant RCTs that tested the effects of omega-3 supplementation on dialysis patients. Standard mean differences (SMDs) for CRP and albumin, mean differences (MDs) for IL-6 and TNF-a, 95% confidence intervals (CIs) were calculated and heterogeneity was assessed with the I2 test. Results: 12 RCTs with 564 dialysis patients were included in the meta-analysis. The dose of omega-3 ranged from 1 to 6 g/d, and the mean follow-up was 3.5 months. Pooled analysis revealed that omega-3 intake significantly reduced serum CRP levels (SMD, À0.52; 95% CI, À0.92 to À0.13; p Z 0.01). However, no statistically significant effects were observed for IL-6, TNF-a and albumin levels. Subgroup meta-analysis suggested that smaller doses (< 3 g/d) or shorter-term interventional duration (< 3 months) could also lower CRP. Conclusion: In our meta-analysis, omega-3 intake significantly lowered the serum CRP levels, but had no effect on albumin concentration. There is no conclusive evidence whether it can modulate the IL-6 and TNF-a level. Large, high-quality trials with hard clinical outcomes are warranted. 
